CDH2 is a predictive biomarker for distant metastasis in early-stage breast cancer (Aleskandarany et al., 2015), that is commonly detected in breast cancer cells and provides a mechanism for transendothelial migration (Qi et al., 2005). The gene discussed is CDH2; the disease is breast cancer.